[Rationale for the use of proteolysis inhibitors as etiopathogenetic agents in respiratory viral infections in children].
D015119:Aminocaproic Acid / Q000627:therapeutic use; D002675:Child, Preschool; D006023:Glycoproteins / Q000037:antagonists & inhibitors; D006801:Humans; D006868:Hydrolysis; D007223:Infant; D009975:Orthomyxoviridae / Q000378:metabolism; D009976:Orthomyxoviridae Infections / Q000188:drug therapy*; D010252:Paramyxoviridae / Q000378:metabolism; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D010253:Respirovirus Infections / Q000188:drug therapy*; D014764:Viral Proteins / Q000037:antagonists & inhibitors
D006023:Glycoproteins; D014764:Viral Proteins; D015119:Aminocaproic Acid
Obosnovanie primeneniia ingibitorov proteoliza kak etiopatogeneticheskikh sredstv pri respiratornykh virusnykh infektsiiakh u deteĭ.